Macquarie University and CasBio Therapeutics Partner to Advance Gene-Editing Therapies for Vision Loss
CasBio Therapeutics and Macquarie University are partnering to develop innovative gene-editing and nanodelivery approaches for glaucoma and retinal neurodegenerative diseases
CASBIO Therapeutics joins Macquarie University’s DeepTech Incubator
We are thrilled to announce that CasBio has officially joined Macquarie University’s DeepTech Incubator. This collaboration will accelerate our work in CRISPR-Cas-based diagnostics, enabling rapid, sensitive, and user-friendly molecular testing at the point of care….